Capital B's EUR 21M Raise: The Warrant Overhang Beneath the Bitcoin Narrative

The Q3 capital table for Capital B reveals an anomaly. The company announced a EUR 21 million private placement on August 31st, structured as units of one share and four warrants. This is not a technical upgrade. It is a financial engineering event with measurable consequences for existing shareholders. The ledger shows 3,145 BTC in the treasury before the raise, moving to 3,415 BTC after. The immediate BTC-per-million-shares metric stays nearly flat at 7.4711. That is the surface. The warrant schedule tells a different story. If all 144,876,280 warrants are exercised over the five-year term, the BTC-per-million-shares figure drops to 5.6730. A 24.1% dilution. The market narrative focuses on Bitcoin accumulation. The data focuses on a structural transfer of value from current holders to future warrant holders. I have spent years auditing treasury company filings, and this pattern—a headline about growth masking a back-end dilution mechanism—is consistent with a specific institutional strategy. The strategy is not flawed on its face. The risk is that the market is pricing the narrative, not the cap table. Context requires a definition of the business model. Capital B is not a protocol. It is a publicly listed Bitcoin Treasury Company. This category was pioneered by MicroStrategy (MSTR) in 2020-2024. The operational model is simple: use capital markets tools—equity, convertibles, warrants—to raise fiat, then convert that fiat into Bitcoin. The value proposition to shareholders is a leveraged, or at least a direct, exposure to Bitcoin price action without holding the asset directly. The balance sheet becomes a proxy for a Bitcoin holding. Key metrics are not revenue or earnings. The core metric is the ratio of BTC held to shares outstanding. As of the last filing, the treasury holds 3,145 BTC. This places Capital B in the small-cap tier of this niche, roughly 1.4% of MSTR's position. They are a follower in a winner-take-most market. The funding environment is favorable during a bull cycle, but the cost of that funding is the dilution embedded in the instrument. The company operates within EU regulatory frameworks, which demands a higher standard of disclosure than a DAO, yet the current announcement leaves gaps. My audit experience in 2025, focusing on MiCA compliance for RWA projects, taught me that the absence of a disclosure is often more informative than the presence of a number. Here, the silence pertains to the older BSA series warrants and the TOBAM facility. The core evidence chain begins with the placement terms. The price is EUR 0.58 per unit for 36,219,070 shares. This immediate placement is neutral to the BTC-per-share ratio. It is a wash. The critical data point is the warrant overhang. Four warrants per share, strike prices at EUR 0.75, EUR 0.98, and EUR 1.27, a five-year maturity. These are deep out-of-the-money relative to the placement price, suggesting the company expects significant price appreciation. But the mechanics of dilution do not wait for the strike price. The potential for issuance is a liability on the existing shareholders' exposure. The math is straightforward. Post-placement, the treasury is 3,415 BTC. If all warrants are exercised, the share count increases by 144,876,280. The BTC-per-million metric declines from 7.4711 to 5.6730. A 24.1% reduction. The company's assertion that the raise "improves the diluted BTC per share" is true only in the immediate spot context. The 8.6% increase in BTC holdings is offset by the 32.8% potential increase in share count. This is a classic structural mismatch. The data confirms the 'heavy warrant dilution risk' highlighted in market analysis. Tracing the source of this risk leads back to the governance authorization. Shareholders have pre-approved a EUR 5 billion capital increase and a EUR 100 billion credit instrument. This is not a permission for a specific raise. This is a blank check. The management team has the authority to dilute the existing base without a single additional shareholder vote. In my 2021 thesis work, I identified a similar disconnect in cross-chain bridge liquidity—the mechanism for growth was the same mechanism for loss. Audit complete. The warrants are the ledger entry that does not lie. A contrarian perspective suggests that the dilution risk might be overpriced by the market, but for the wrong reasons. The warrants are unlikely to be exercised in full at the current strikes if the stock remains flat. If the price stays below EUR 0.75, the warrants expire worthless, and the dilution never materializes. The danger is not the warrant exercise itself, but the signal it sends. The company is willing to use aggressive financial instruments to acquire Bitcoin. This suggests that access to cheaper capital—like the convertible notes MSTR uses—has been limited for this entity. The choice of warrants over convertibles is a data point on the company's credit profile. The correlation between Bitcoin's price and Capital B's stock price is high, but the causation of shareholder loss is primarily a function of the capital structure, not the asset price. If Bitcoin rallies hard, the warrants are exercised, and the new BTC purchased with those proceeds may not be sufficient to maintain the per-share ratio. The company is effectively short volatility in its own equity to go long volatility in Bitcoin. A second blind spot is the market's focus on total BTC holdings. The headline of '3400 BTC' sounds like progress. Sophisticated institutional investors are looking at the per-share metric. They will see the 24.1% overhang and discount the stock accordingly. This is a classic asymmetry: retail sees the top-line asset growth, institutional sees the bottom-line equity dilution. Takeaway signals for the next week are focused on on-chain and secondary market flows. The first signal is the movement of the EUR 21 million. Follow the outflows. If the funds are transferred to an exchange within 48 hours of receipt, that is a signal of immediate execution, which is neutral. If the funds are parked in a custodial address for weeks, that suggests a market-timing strategy that could indicate a lack of confidence in the current price level. The second signal is the trading volume of the stock itself. A volume spike without a corresponding price increase is a sign of distribution. The third signal is the company's next disclosure. If the next announcement mentions a drawdown on the TOBAM facility or the issuance of more BSA series warrants, the dilution narrative accelerates. The forward-looking judgment is that the sustainable path is for the company to buy Bitcoin on any dip and hope the stock price appreciates faster than the warrant schedule. If Bitcoin enters a bear phase, the financing window closes. The capital available is a trap, not a moat. The question for the investor is not 'what is the price of Bitcoin?', but 'what is the cost of the capital used to buy it?'. The chain records all. The cap table records more. The regulatory compliance framework adds another layer. Under EU MiCA regulations, the company must maintain transparency regarding asset backing. The lack of full disclosure on the BSA warrants and the TOBAM facility is a compliance gap. In an audit, a missing signature invalidates the entire document. Here, the missing data on the dilution schedule undermines the 'proof of reserve' calculation. The company is holding assets but has contingent liabilities in the form of warrants that are not fully marked to market. This is a known issue. The 'compliance first' approach for any RWA project requires a full ledger of liabilities. Capital B has provided a ledger of assets but a partial ledger of liabilities. The potential for a regulatory query is medium, but the potential for a shareholder lawsuit regarding misrepresentation is higher. I have seen this in the 2025 RWA audits—projects fail not on the asset side, but on the liability side. The warrants are a liability on the equity value. The governance structure, with its massive pre-approval for dilution, is a red flag for institutional investors. The management has the tools to protect shareholders but has chosen a structure that maximizes optionality for the company, not the existing investors. From a competitive landscape perspective, this raise puts Capital B in a weak position. MSTR uses convertible notes, which are less immediately dilutive. Metaplanet's structure is simpler. Capital B's complex warrant structure is a symptom of a company that cannot access prime institutional capital. The funding is likely high-yield in nature, which means the 'cost' of the Bitcoin they buy is higher than the market price. This is not a sustainable moat. The only winner in this game is the one with the lowest cost of capital. The data shows that Capital B has a higher cost of capital than its peers. The market positioning is 'European MSTR', but the structure is 'European distressed debt'. The market will eventually price this difference. The divergence between the narrative and the structure is the opportunity for short sellers. The information value of this event is high, not because of the EUR 21 million, but because it reveals the financial health and strategic desperation of a small-cap treasury company. The takeaway is clear. An audit of the capital structure is more important than an audit of the treasury wallet. The treasury wallet shows the assets. The capital structure shows the claims on those assets. The claims are growing faster than the assets. Until the company closes this gap by buying more Bitcoin or repurchasing warrants, the existing shareholders are on the wrong side of the equation. The next signal is the warrant exercise ratio. That is the metric that will define the stock's trajectory. Verify before you trade. The ledger doesn't make mistakes. The prospectus sometimes does.